| Michelle V Wong, DO | |
|
208 Mill Rd, Fairhaven, MA 02719-5208 | |
| (508) 973-2661 | |
| (508) 973-0314 |
| Full Name | Michelle V Wong |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 11 Years |
| Location | 208 Mill Rd, Fairhaven, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679912539 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 268676 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southcoast Hospitals Group | Fall river, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southcoast Physicians Group Inc | 0749171957 | 746 |
News Archive
Imagine using the same process that goes into building video games to help investigators solve real-world crimes. Through a new grant, that's what researchers at North Carolina State University plan to do.
The 25.8 million Americans who have diabetes may soon be free of finger pricks and daily insulin dosing. Mayo Clinic endocrinologists Yogish Kudva, M.B.B.S., and Ananda Basu, M.B.B.S., M.D., are developing an artificial pancreas that will deliver insulin automatically and with an individualized precision never before possible.
Scientists at The University of Nottingham are to investigate whether giving recovering stroke patients a triple cocktail of medicines could reduce their chances of a further attack.
OriGene Technologies, Inc. has recently achieved a significant milestone in its quest for developing an assay for every human protein through the release of 1,500 mouse monoclonal antibodies under the TrueMAB brand. Each TrueMAB antibody is specifically developed with full-length human proteins produced in HEK293T cells and validated for critical research and diagnostic needs requiring improved antibody sensitivity and specificity.
Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review two supplemental New Drug Applications (sNDAs) for the use of LATUDA as 1) monotherapy and 2) adjunctive therapy to lithium or valproate, both to treat adult patients with depressive episodes associated with bipolar I disorder (bipolar depression).
› Verified 3 days ago
| Entity Name | Lahey Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538194980 PECOS PAC ID: 2264336528 Enrollment ID: O20031120000097 |
News Archive
Imagine using the same process that goes into building video games to help investigators solve real-world crimes. Through a new grant, that's what researchers at North Carolina State University plan to do.
The 25.8 million Americans who have diabetes may soon be free of finger pricks and daily insulin dosing. Mayo Clinic endocrinologists Yogish Kudva, M.B.B.S., and Ananda Basu, M.B.B.S., M.D., are developing an artificial pancreas that will deliver insulin automatically and with an individualized precision never before possible.
Scientists at The University of Nottingham are to investigate whether giving recovering stroke patients a triple cocktail of medicines could reduce their chances of a further attack.
OriGene Technologies, Inc. has recently achieved a significant milestone in its quest for developing an assay for every human protein through the release of 1,500 mouse monoclonal antibodies under the TrueMAB brand. Each TrueMAB antibody is specifically developed with full-length human proteins produced in HEK293T cells and validated for critical research and diagnostic needs requiring improved antibody sensitivity and specificity.
Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review two supplemental New Drug Applications (sNDAs) for the use of LATUDA as 1) monotherapy and 2) adjunctive therapy to lithium or valproate, both to treat adult patients with depressive episodes associated with bipolar I disorder (bipolar depression).
› Verified 3 days ago
| Entity Name | Southcoast Physicians Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336137629 PECOS PAC ID: 0749171957 Enrollment ID: O20040920000138 |
News Archive
Imagine using the same process that goes into building video games to help investigators solve real-world crimes. Through a new grant, that's what researchers at North Carolina State University plan to do.
The 25.8 million Americans who have diabetes may soon be free of finger pricks and daily insulin dosing. Mayo Clinic endocrinologists Yogish Kudva, M.B.B.S., and Ananda Basu, M.B.B.S., M.D., are developing an artificial pancreas that will deliver insulin automatically and with an individualized precision never before possible.
Scientists at The University of Nottingham are to investigate whether giving recovering stroke patients a triple cocktail of medicines could reduce their chances of a further attack.
OriGene Technologies, Inc. has recently achieved a significant milestone in its quest for developing an assay for every human protein through the release of 1,500 mouse monoclonal antibodies under the TrueMAB brand. Each TrueMAB antibody is specifically developed with full-length human proteins produced in HEK293T cells and validated for critical research and diagnostic needs requiring improved antibody sensitivity and specificity.
Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review two supplemental New Drug Applications (sNDAs) for the use of LATUDA as 1) monotherapy and 2) adjunctive therapy to lithium or valproate, both to treat adult patients with depressive episodes associated with bipolar I disorder (bipolar depression).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michelle V Wong, DO 200 Mill Rd Ste 180, Fairhaven, MA 02719-5255 Ph: (508) 973-2000 | Michelle V Wong, DO 208 Mill Rd, Fairhaven, MA 02719-5208 Ph: (508) 973-2661 |
News Archive
Imagine using the same process that goes into building video games to help investigators solve real-world crimes. Through a new grant, that's what researchers at North Carolina State University plan to do.
The 25.8 million Americans who have diabetes may soon be free of finger pricks and daily insulin dosing. Mayo Clinic endocrinologists Yogish Kudva, M.B.B.S., and Ananda Basu, M.B.B.S., M.D., are developing an artificial pancreas that will deliver insulin automatically and with an individualized precision never before possible.
Scientists at The University of Nottingham are to investigate whether giving recovering stroke patients a triple cocktail of medicines could reduce their chances of a further attack.
OriGene Technologies, Inc. has recently achieved a significant milestone in its quest for developing an assay for every human protein through the release of 1,500 mouse monoclonal antibodies under the TrueMAB brand. Each TrueMAB antibody is specifically developed with full-length human proteins produced in HEK293T cells and validated for critical research and diagnostic needs requiring improved antibody sensitivity and specificity.
Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review two supplemental New Drug Applications (sNDAs) for the use of LATUDA as 1) monotherapy and 2) adjunctive therapy to lithium or valproate, both to treat adult patients with depressive episodes associated with bipolar I disorder (bipolar depression).
› Verified 3 days ago
Todd F Roberts, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 206 Mill Rd, Fairhaven, MA 02719 Phone: 508-973-3000 Fax: 508-973-3119 | |
Dr. Nicholas Robert Ondrasik, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 208 Mill Rd, Fairhaven, MA 02719 Phone: 508-973-2224 Fax: 508-973-0394 | |
Dr. Alexis Pappas, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 208 Mill Rd, Fairhaven, MA 02719 Phone: 508-973-2661 Fax: 508-973-0314 | |
Elizabeth M Blanchard, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 206 Mill Rd, Fairhaven, MA 02719 Phone: 508-973-3000 Fax: 508-973-3119 | |
Dr. Abena A. Addo, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 208 Mill Rd, Fairhaven, MA 02719 Phone: 508-996-1800 Fax: 508-992-7906 | |
Chandra S Reddivari, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 200 Mill Road, Suite 190, Fairhaven, MA 02719 Phone: 508-973-0857 Fax: 508-973-2176 | |
Nosheen Javed, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 208 Mill Rd, Fairhaven, MA 02719 Phone: 508-973-2207 Fax: 508-973-2505 |